The Partnership to Fight Chronic Disease is urging congressional Medicaid advisers to reject recommendations to increase rebates and impose an additional inflationary rebate on drugs that receive accelerated approvals. The Medicaid and CHIP Payment and Access Commission will vote Thursday (April 8) on those very recommendations. “We are troubled by the commentary at the last MACPAC meeting that insinuates that these drugs somehow evade FDA scrutiny and are unsafe or ineffective,” the Partnership to Fight Chronic Disease states in an...